Adage Capital Partners
TSHA icon

Adage Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History

Adage Capital Partners’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,328,000
Closed -$7.3M – 1076
2025
Q4 		$7.3M Sell
1,328,000
-2,000,000
-60% -$9.71M 0.01% 718
2025
Q3 		$10.9M Sell
3,328,000
-1,511,000
-31% -$4.28M 0.02% 611
2025
Q2 		$11.2M Buy
+4,839,000
New +$10.5M 0.02% 592
2025
Q1 		– Sell
-5,000,000
Closed -$8.65M – 945
2024
Q4 		$8.65M Buy
+5,000,000
New +$10.4M 0.02% 642
2024
Q2 		– Sell
-220,000
Closed -$631K – 939
2024
Q1 		$631K Sell
220,000
-200,000
-48% -$417K ﹤0.01% 803
2023
Q4 		$743K Sell
420,000
-1,080,000
-72% -$2.15M ﹤0.01% 771
2023
Q3 		$4.74M Buy
+1,500,000
New +$2.8M 0.01% 670

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM